课题基金 / 基金详情

项目摘要

项目成果

Gabrielle Fredman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Atherosclerotic cardiovascular disease (CVD) is the leading cause of death in the industrialized world. Failed resolution of a chronic inflammatory response is an important driving force in the progression of atherosclerosis. Resolution is mediated by the critical balance between specialized pro-resolving mediators (SPMs) such as lipoxins and resolvins and pro-inflammatory factors like leukotrienes (LTs) and prostaglandins (PGs). Previous work from our lab and others suggest that SPMs are defectively synthesized in plaques and that restoration of SPMs prevents atherosclerosis progression in mice. Gaps remain in our understanding as to a) what cellular processes derange the synthesis of SPMs in protective actions of SPMs in atherosclerosis. Therefore, the plaques and b) mechanisms associated with the overall objective of this proposal is to understand new mechanisms of dysregulated resolution in atherosclerosis and to harness new SPM signaling pathways towards a novel treatment strategy. Cellular senescence is an irreversible cell cycle arrest that leads to a highly pro-inflammatory phenotype called the senescence-associated secretory phenotype (SASP). Prominent features of senescent cells (SCs) include elevated levels of COX2 and PGs and heightened glycolysis. SCs recently emerged as a driver of plaque necrosis but mechanisms are poorly understood. Our new work suggests that senescence impairs endogenous resolution programs and that key SPMs can limit the SASP. We proposed a series of studies to identify the mechanisms associated with senescence and impaired resolution (Aim I), the link between myeloid senescent cells and SPM formation in plaques (Aim II) and mechanisms underlying how hypercholesterolemia impacts senescence and SPM synthesis (Aim III). The link between dysregulated resolution programs and senescence is a completely new and unexplored area of research that may reveal new treatment strategies for atherosclerosis that are complementary to those that currently exist.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.stemcr.2021.10.011
发表时间: 2021-12-14
期刊: Stem cell reports
影响因子: 5.9
作者: [Howard JE, Smith JNP, Fredman G, MacNamara KC]
通讯作者: MacNamara KC
DOI: 10.1161/atvbaha.120.315758
发表时间: 2021-03
期刊: Arteriosclerosis, thrombosis, and vascular biology
影响因子: --
作者: [Hosseini Z, Marinello M, Decker C, Sansbury BE, Sadhu S, Gerlach BD, Bossardi Ramos R, Adam AP, Spite M, Fredman G]
通讯作者: Fredman G
DOI: 10.4049/jimmunol.2100284
发表时间: 2021-10-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Sadhu S, Decker C, Sansbury BE, Marinello M, Seyfried A, Howard J, Mori M, Hosseini Z, Arunachalam T, Finn AV, Lamar JM, Jourd'heuil D, Guo L, MacNamara KC, Spite M, Fredman G]
通讯作者: Fredman G
DOI: 10.1186/s13293-023-00513-y
发表时间: 2023-05-19
期刊: Biology of sex differences
影响因子: 7.9
作者: []
通讯作者:
6
    Inflammation-resolution impairments in aging and atherosclerosis
    • 批准号:
      10724859
    • 项目类别:
    • 资助金额:
      $80.21万
    • 财政年份:
      2023
    • 负责人:
      Gabrielle Fredman
    • 依托单位:
    Senescence dysregulates of inflammation-resolution programs in atherosclerosis
    • 批准号:
      10427260
    • 项目类别:
    • 资助金额:
      $61.78万
    • 财政年份:
      2020
    • 负责人:
      Gabrielle Fredman
    • 依托单位:
    Senescence dysregulates of inflammation-resolution programs in atherosclerosis
    • 批准号:
      10025692
    • 项目类别:
    • 资助金额:
      $64.27万
    • 财政年份:
      2020
    • 负责人:
      Gabrielle Fredman
    • 依托单位:
    Senescence dysregulates of inflammation-resolution programs in atherosclerosis
    • 批准号:
      10333044
    • 项目类别:
    • 资助金额:
      $4.84万
    • 财政年份:
      2020
    • 负责人:
      Gabrielle Fredman
    • 依托单位:
    海外基金